Topline results were announced from a trial evaluating albuterol/budesonide inhaler in patients with intermittent or mild persistent asthma.

Levalbuterol and albuterol act quickly to open your airways during an asthma attack. Find out more about key differences and ...

Climate change could drive up demand for drugs to treat asthma, kidney disease and Alzheimer's and add to supply chain ...

The IHS is supposed to provide free care to Native Americans, but it does so only at scattered clinics and hospitals the ...

In the phase 3b BATURA trial, Airsupra—a pressurized metered-dose inhaler containing albuterol and budesonide—significantly ...

The U.S. government plans to release a list of 101 generic drugs, available to Medicare recipients for no more than $2 each. These drugs, including penicillin and albuterol, won't require prior ...

AstraZeneca's Airsupra (albuterol/budesonide) met the primary endpoint in the Phase III BATURA trial, significantly reducing ...

AstraZeneca's inhaled rescue medication, Airsupra (albuterol/budesonide), has shown significant efficacy in reducing the risk ...

Learn about the Biden administration's plan to offer Medicare pilot program for affordable generic drugs, including common ...

AstraZeneca’s BATURA phase IIIb trial of Airsupra in patients with intermittent or mild persistent asthma meets primary endpoint: Cambridge, UK Tuesday, October 8, 2024, 09:00 H ...

UK-based pharmaceutical company AstraZeneca has reported that its Phase IIIb BATURA trial of Airsupra (albuterol/budesonide) ...

AZN inks an agreement with CSPC Pharmaceutical to develop a novel lipid-lowering therapy targeting various cardiovascular ...